SCHEMBL360463

SCHEMBL360463

CCC([NH])CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910830 1.00
SCHEMBL752513 1.00
SCHEMBL589923 0.76
SCHEMBL106581 0.76
SCHEMBL11874595 0.73
SCHEMBL2913590 0.73
SCHEMBL4035952 0.73
SCHEMBL6153131 0.67
SCHEMBL3157530 0.67
SCHEMBL3085085 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180298026-A1 Pyrazolo[1,5a]Pyrimidine Derivatives as IRAK4 Modulators HOFFMANN-LA ROCHE INC. 2018-10-18 US claimed
US-10023589-B2 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators HOFFMANN-LA ROCHE INC. (US) 2018-07-17 US claimed
EP-3252054-A1 PYRAZOLO[1,5A]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS F. Hoffmann-La Roche AG (CH) 2017-12-06 EP claimed
WO-2017153789-A1 BENZO[B]THIOPHENE DERIVATIVES AND THEIR USE FOR THE INHIBITION OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES (FGFRS) FOR THE USE OF NEO- AND HYPERPLASIA THERAPIES VICHEM CHEMIE KUTATÓ KFT. (HU) 2017-09-14 WO claimed
EP-2593457-B1 PYRAZOLO[1,5A]PYRIMIDINE AND THIENO[3,2B]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS HOFFMANN LA ROCHE (CH) 2017-08-23 EP claimed
US-20160207936-A1 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS HOFFMANN-LA ROCHE INC. 2016-07-21 US claimed
US-20140303149-A1 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS HOFFMANN-LA ROCHE INC. (US) 2014-10-09 US claimed
US-20140249165-A1 PURINE DERIVATIVES FOR TREATMENT OF CYSTIC DISEASES GENZYME CORPORATION (US) 2014-09-04 US claimed
EP-2617423-A1 Purine derivatives for the treatment of cystic diseases GENZYME CORPORATION (US) 2013-07-24 EP claimed
US-8492420-B2 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) 2013-07-23 US claimed
US-6514977-B1 For treating p38 kinase mediated disorders G.D. SEARLE & COMPANY 2003-02-04 US claimed
US-6423713-B1 Substituted pyrazoles as p38 kinase inhibitors G. D. SEARLE & COMPANY 2002-07-23 US claimed
US-5336445-A Aqueous mixtures with polar solvents for removal of grease and heavy soils from glass without streaking THE PROCTER & GAMBLE COMPANY (US) 1994-08-09 US claimed
EP-0513240-A4 LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC DETERGENT SURFACTANT AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL 1993-10-20 EP claimed
EP-0513240-A1 LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC DETERGENT SURFACTANT AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL THE PROCTER & GAMBLE COMPANY (US) 1992-11-19 EP claimed
EP-0200024-B1 3-CYANO-PYRIDINES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE ARZNEIMITTELWERK DRESDEN GmbH (DE) 1992-07-01 EP claimed
WO-1991011505-A1 LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC DETERGENT SURFACTANT AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL THE PROCTER & GAMBLE COMPANY (US) 1991-08-08 WO claimed
EP-0200024-A2 3-Cyano-pyridines, process for their preparation and their pharmaceutical use ARZNEIMITTELWERK DRESDEN GmbH (DE) 1986-11-05 EP claimed
EP-0062827-B1 NOVEL BENZAMIDE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD (JP) 1986-07-23 EP claimed
EP-0062827-A2 Novel benzamide derivatives KYOWA HAKKO KOGYO CO., LTD (JP) 1982-10-20 EP claimed